Women continue to represent a tiny sliver of investors in Silicon Valley and other tech hubs. But in health tech, the divide isn’t quite as stark as in other sectors.
New research from the early-stage investment fund Rock Health found that women make up about 11 percent of health-tech partners, a slight decrease from 11.4 percent in 2015. The average overall for venture capital is just 7 percent.
Click below to view the latest news and updates from Arboretum Ventures.
Pear Therapeutics, the leader in prescription digital therapeutics, today announced that it has received an Expedited Access Pathway (EAP) designation from the U.S. Food and Drug Administration (FDA) for its reSET-O™ Prescription Digital Therapeutic, the first of its kind designed for treating Opioid Use Disorder (OUD).
Strata Oncology, Inc. (Strata), a precision oncology company, announced a collaboration with the University of California San Francisco (UCSF) to launch Stratify Prostate™ a unique initiative focused on expanding access to tumor sequencing nationwide for men with advanced prostate cancer and to dramatically accelerate enrollment into relevant targeted therapy trials.